{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:19:29Z","timestamp":1792181969420,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA138212-01"],"award-info":[{"award-number":["1R01CA138212-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liddy Shriver Sarcoma Initiative"},{"DOI":"10.13039\/100013851","name":"Pablove Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013851","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005130","name":"Giant","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heather Brooke Foundation"},{"name":"Love for Luca Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s10585-015-9738-x","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T01:26:36Z","timestamp":1439774796000},"page":"703-715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["An orthotopic xenograft model with survival hindlimb amputation allows investigation of the effect of tumor microenvironment on sarcoma metastasis"],"prefix":"10.1007","volume":"32","author":[{"given":"Seth D.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle W.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,18]]},"reference":[{"key":"9738_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00130404-200507000-00008","volume":"11","author":"PC Adamson","year":"2005","unstructured":"Adamson PC, Blaney SM (2005) New approaches to drug development in pediatric oncology. Cancer J 11:324\u2013330","journal-title":"Cancer J"},{"key":"9738_CR2","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1158\/1078-0432.CCR-13-2574","volume":"20","author":"C Khanna","year":"2014","unstructured":"Khanna C, Fan TM, Gorlick R et al (2014) Toward a drug development path that targets metastatic progression in osteosarcoma. Clin Cancer Res 20:4200\u20134209","journal-title":"Clin Cancer Res"},{"key":"9738_CR3","doi-asserted-by":"publisher","first-page":"8985","DOI":"10.1158\/0008-5472.CAN-07-1971","volume":"67","author":"SE Kern","year":"2007","unstructured":"Kern SE, Shibata D (2007) The fuzzy math of solid tumor stem cells: a perspective. Cancer Res 67:8985\u20138988","journal-title":"Cancer Res"},{"key":"9738_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00130404-200507000-00006","volume":"11","author":"K Krishnan","year":"2005","unstructured":"Krishnan K, Khanna C, Helman LJ (2005) The biology of metastases in pediatric sarcomas. Cancer J 11:306\u2013313","journal-title":"Cancer J"},{"key":"9738_CR5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/nm.3391","volume":"19","author":"L Wan","year":"2013","unstructured":"Wan L, Pantel K, Kang Y (2013) Tumor metastasis: moving new biological insights into the clinic. Nat Med 19:1450\u20131464","journal-title":"Nat Med"},{"key":"9738_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nprot.2007.25","volume":"2","author":"CL Morton","year":"2007","unstructured":"Morton CL, Houghton PJ (2007) Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc 2:247\u2013250","journal-title":"Nat Protoc"},{"key":"9738_CR7","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1054\/bjoc.2001.1796","volume":"84","author":"JI Johnson","year":"2001","unstructured":"Johnson JI, Decker S, Zaharevitz D et al (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84:1424\u20131431","journal-title":"Br J Cancer"},{"key":"9738_CR8","first-page":"S134","volume":"2","author":"RS Kerbel","year":"2003","unstructured":"Kerbel RS (2003) Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved. Cancer Biol Ther 2:S134\u2013s139","journal-title":"Cancer Biol Ther"},{"key":"9738_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrc3370","volume":"12","author":"RE Norris","year":"2012","unstructured":"Norris RE (2012) Adamson PC Challenges and opportunities in childhood cancer drug development. Nat Rev Cancer 12:776\u2013782","journal-title":"Nat Rev Cancer"},{"key":"9738_CR10","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: The arrive guidelines for reporting animal research. PLoS Biol 8:e1000412","journal-title":"PLoS Biol"},{"key":"9738_CR11","doi-asserted-by":"publisher","first-page":"6849","DOI":"10.1158\/0008-5472.CAN-04-2201","volume":"64","author":"SP Hussain","year":"2004","unstructured":"Hussain SP, Trivers GE, Hofseth LJ et al (2004) Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res 64:6849\u20136853","journal-title":"Cancer Res"},{"key":"9738_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/pbc.22797","volume":"57","author":"MA Smith","year":"2011","unstructured":"Smith MA, Maris JM, Lock R et al (2011) Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing program. Pediatr Blood Cancer 57:268\u2013274","journal-title":"Pediatr Blood Cancer"},{"key":"9738_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jdermsci.2010.12.009","volume":"61","author":"X Yan","year":"2011","unstructured":"Yan X, Takahara M, Xie L et al (2011) Arginine metabolism in soft tissue sarcoma. J Dermatol Sci 61:211\u2013215","journal-title":"J Dermatol Sci"},{"key":"9738_CR14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/bies.20324","volume":"27","author":"EL Williams","year":"2005","unstructured":"Williams EL (2005) Djamgoz MBA Nitric oxide and metastatic cell behaviour. Bioessays 27:1228\u20131238","journal-title":"Bioessays"},{"key":"9738_CR15","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437","journal-title":"Nat Med"},{"key":"9738_CR16","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.4049\/jimmunol.1103660","volume":"188","author":"S Tanaka","year":"2012","unstructured":"Tanaka S, Saito Y, Kunisawa J et al (2012) Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD\/SCID\/IL2r\u03b3KO mice. J Immunol 188:6145\u20136155","journal-title":"J Immunol"},{"key":"9738_CR17","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K et al (2002) NOD\/SCID\/\u03b3c null mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175\u20133182","journal-title":"Blood"},{"key":"9738_CR18","first-page":"4890","volume":"53","author":"\u00d6 Berlin","year":"1993","unstructured":"Berlin \u00d6, Samid D, Donthineni-Rao R, Akeson W, Amiel D, Woods VL Jr (1993) Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Res 53:4890\u20134895","journal-title":"Cancer Res"},{"key":"9738_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3171\/jns.1995.83.2.0308","volume":"83","author":"P Huang","year":"1995","unstructured":"Huang P, Allam A, Taghian A, Freeman J, Duffy M, Suit HD (1995) Growth and metastatic behavior of five human glioblastomas compared with nine other histological types of human tumor xenografts in SCID mice. J Neurosurg 83:308\u2013315","journal-title":"J Neurosurg"},{"key":"9738_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1023\/A:1006767007547","volume":"18","author":"C Khanna","year":"2000","unstructured":"Khanna C, Prehn J, Yeung C, Caylor J, Tsokos M, Helman L (2000) An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin Exp Metastasis 18:261\u2013271","journal-title":"Clin Exp Metastasis"},{"key":"9738_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10585-005-0365-9","volume":"22","author":"HH Luu","year":"2005","unstructured":"Luu HH, Kang Q, Jong KP et al (2005) An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 22:319\u2013329","journal-title":"Clin Exp Metastasis"},{"key":"9738_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/07357900802491477","volume":"27","author":"J Yuan","year":"2009","unstructured":"Yuan J, Ossendorf C, Szatkowski JP et al (2009) Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases. Cancer Investig 27:435\u2013442","journal-title":"Cancer Investig"},{"key":"9738_CR23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nprot.2012.031","volume":"7","author":"AMMJ Duyverman","year":"2012","unstructured":"Duyverman AMMJ, Steller EJA, Fukumura D, Jain RK, Duda DG (2012) Studying primary tumor-associated fibroblast involvement in cancer metastasis in mice. Nat Protoc 7:756\u2013762","journal-title":"Nat Protoc"},{"key":"9738_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/(SICI)1096-9098(199706)65:2<123::AID-JSO9>3.0.CO;2-9","volume":"65","author":"T Chao","year":"1997","unstructured":"Chao T, Greager JA (1997) Experimental pulmonary sarcoma metastases in athymic nude mice. J Surg Oncol 65:123\u2013126","journal-title":"J Surg Oncol"},{"key":"9738_CR25","first-page":"463","volume":"10","author":"M Pocard","year":"1996","unstructured":"Pocard M, Tsukui H, Salmon R, Dutrillaux B, Poupon MF (1996) Efficiency of orthotopic xenograft models for human colon cancers. In Vivo 10:463\u2013469","journal-title":"In Vivo"},{"key":"9738_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2353\/ajpath.2007.060929","volume":"170","author":"JE Talmadge","year":"2007","unstructured":"Talmadge JE, Singh RK, Fidler IJ, Raz A (2007) Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 170:793\u2013804","journal-title":"Am J Pathol"},{"key":"9738_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.celrep.2012.12.013","volume":"3","author":"K Joo","year":"2013","unstructured":"Joo K, Kim J, Jin J et al (2013) Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. Cell Rep 3:260\u2013273","journal-title":"Cell Rep"},{"key":"9738_CR28","first-page":"3522","volume":"44","author":"JM Kozlowski","year":"1984","unstructured":"Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, Hart IR (1984) Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44:3522\u20133529","journal-title":"Cancer Res"},{"key":"9738_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-110","author":"BL Hylander","year":"2013","unstructured":"Hylander BL, Punt N, Tang H et al (2013) Origin of the vasculature supporting growth of primary patient tumor xenografts. J Transl Med. doi:\n                    10.1186\/1479-5876-11-110","journal-title":"J Transl Med"},{"key":"9738_CR30","doi-asserted-by":"publisher","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","volume":"29","author":"KA Kigerl","year":"2009","unstructured":"Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29:13435\u201313444","journal-title":"J Neurosci"},{"key":"9738_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00533","author":"Z Yang","year":"2014","unstructured":"Yang Z, Ming X (2014) Functions of arginase isoforms in macrophage inflammatory responses: Impact on cardiovascular diseases and metabolic disorders. Front Immunol. doi:\n                    10.3389\/fimmu.2014.00533","journal-title":"Front Immunol"},{"key":"9738_CR32","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1158\/1078-0432.CCR-10-2047","volume":"17","author":"EP Buddingh","year":"2011","unstructured":"Buddingh EP, Kuijjer ML, Duim RAJ et al (2011) Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents. Clin Cancer Res 17:2110\u20132119","journal-title":"Clin Cancer Res"},{"key":"9738_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.niox.2014.08.003","volume":"43","author":"RYS Cheng","year":"2014","unstructured":"Cheng RYS, Basudhar D, Ridnour LA et al (2014) Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways. Nitric Oxide Biol Chem 43:17\u201328","journal-title":"Nitric Oxide Biol Chem"},{"key":"9738_CR34","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1073\/pnas.1401799111","volume":"111","author":"JL Heinecke","year":"2014","unstructured":"Heinecke JL, Ridnour LA, Cheng RYS et al (2014) Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression. Proc Natl Acad Sci USA 111:6323\u20136328","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"9738_CR35","doi-asserted-by":"publisher","first-page":"e12715","DOI":"10.1371\/journal.pone.0012715","volume":"5","author":"N Mayorek","year":"2010","unstructured":"Mayorek N, Naftali-Shani N, Grunewald M (2010) Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity. PloS One 5(9):e12715","journal-title":"PloS One"},{"key":"9738_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1158\/1535-7163.MCT-09-0774","volume":"9","author":"E Kobayashi","year":"2010","unstructured":"Kobayashi E, Masuda M, Nakayama R et al (2010) Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma. Mol Cancer Ther 9:535\u2013544","journal-title":"Mol Cancer Ther"},{"key":"9738_CR37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jim.2007.11.012","volume":"332","author":"MI Harrell","year":"2008","unstructured":"Harrell MI, Iritani BM, Ruddell A (2008) Lymph node mapping in the mouse. J Immunol Methods 332:170\u2013174","journal-title":"J Immunol Methods"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-015-9738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-015-9738-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-015-9738-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-015-9738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T23:00:51Z","timestamp":1589410851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-015-9738-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,18]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["9738"],"URL":"https:\/\/doi.org\/10.1007\/s10585-015-9738-x","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,18]]},"assertion":[{"value":"14 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no actual or potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standard of the institution at which the studies were conducted. This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal rights"}}]}}